J2KBIO Co., Ltd. (KOSDAQ:420570)

J2KBIO Statistics

Total Valuation

J2KBIO has a market cap or net worth of KRW 56.02 billion. The enterprise value is 46.78 billion.

Market Cap	56.02B
Enterprise Value	46.78B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

J2KBIO has 5.85 million shares outstanding. The number of shares has increased by 10.17% in one year.

Current Share Class	5.85M
Shares Outstanding	5.85M
Shares Change (YoY)	+10.17%
Shares Change (QoQ)	+1.56%
Owned by Insiders (%)	62.03%
Owned by Institutions (%)	6.75%
Float	2.22M

Valuation Ratios

The trailing PE ratio is 47.41.

PE Ratio	47.41
Forward PE	n/a
PS Ratio	1.93
PB Ratio	1.74
P/TBV Ratio	1.76
P/FCF Ratio	n/a
P/OCF Ratio	14.93
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.39, with an EV/FCF ratio of -46.06.

EV / Earnings	40.38
EV / Sales	1.61
EV / EBITDA	20.39
EV / EBIT	51.57
EV / FCF	-46.06

Financial Position

The company has a current ratio of 7.60, with a Debt / Equity ratio of 0.04.

Current Ratio	7.60
Quick Ratio	6.21
Debt / Equity	0.04
Debt / EBITDA	0.51
Debt / FCF	-1.15
Interest Coverage	25.98

Financial Efficiency

Return on equity (ROE) is 3.74% and return on invested capital (ROIC) is 1.70%.

Return on Equity (ROE)	3.74%
Return on Assets (ROA)	1.56%
Return on Invested Capital (ROIC)	1.70%
Return on Capital Employed (ROCE)	2.72%
Revenue Per Employee	538.41M
Profits Per Employee	21.46M
Employee Count	54
Asset Turnover	0.80
Inventory Turnover	5.93

Taxes

Income Tax	-118.37M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.41% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-46.41%
50-Day Moving Average	9,801.60
200-Day Moving Average	10,282.25
Relative Strength Index (RSI)	51.80
Average Volume (20 Days)	12,465

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, J2KBIO had revenue of KRW 29.07 billion and earned 1.16 billion in profits. Earnings per share was 202.05.

Revenue	29.07B
Gross Profit	10.75B
Operating Income	907.10M
Pretax Income	1.04B
Net Income	1.16B
EBITDA	2.29B
EBIT	907.10M
Earnings Per Share (EPS)	202.05

Balance Sheet

The company has 10.40 billion in cash and 1.17 billion in debt, giving a net cash position of 9.24 billion or 1,579.45 per share.

Cash & Cash Equivalents	10.40B
Total Debt	1.17B
Net Cash	9.24B
Net Cash Per Share	1,579.45
Equity (Book Value)	32.19B
Book Value Per Share	5,504.47
Working Capital	16.68B

Cash Flow

In the last 12 months, operating cash flow was 3.75 billion and capital expenditures -4.77 billion, giving a free cash flow of -1.02 billion.

Operating Cash Flow	3.75B
Capital Expenditures	-4.77B
Free Cash Flow	-1.02B
FCF Per Share	-173.69

Margins

Gross margin is 36.98%, with operating and profit margins of 3.12% and 3.99%.

Gross Margin	36.98%
Operating Margin	3.12%
Pretax Margin	3.58%
Profit Margin	3.99%
EBITDA Margin	7.89%
EBIT Margin	3.12%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 2.11%.

Dividend Per Share	200.00
Dividend Yield	2.11%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	98.95%
Buyback Yield	-10.17%
Shareholder Yield	-8.08%
Earnings Yield	2.07%
FCF Yield	-1.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

J2KBIO has an Altman Z-Score of 14.41 and a Piotroski F-Score of 6.

Altman Z-Score	14.41
Piotroski F-Score	6